Bacaltchuk J, Hay P, Trefiglio R, Mari JJ; International Cochrane Colloquium (6th : 1998 : Baltimore, Md.).
Syst Rev Evid Action Int Cochrane Colloq 6th 1998 Baltim Md. 1998; 6: 90.
Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil.
BACKGROUND: BN is an eating disorder characterized by uncontrolled compulsive eating binges, followed by recurrent use of self-induced purging such as vomiting, laxative abuse, or other inappropriate compensatory methods to prevent weight gain. The prevalence among adolescent and young adult females is approximately 1%-3% (APA 1994). This review attempted to systematically evaluate the use of antidepressants compared to placebo for the treatment of BN. OBJECTIVES: The primary objective of this review was to determine whether antidepressants were clinically effective for the treatment of bulimia nervosa. We also intended to examine whether there was a differential effect for the various classes/types of antidepressants regarding their effectiveness and tolerability. METHODS: Trials were identified through electronic searching, handsearching of references, pharmaceutical companies and personal contact with investigators. The methodological quality of the trials was assessed using the criteria described in the Cochrane Handbook (Mulrow 1997) and the Jadad Scale (Jadad 1996). Dichotomous outcomes were analysed by calculating Peto odds ratios (OR) and 95% confidence intervals for each trial. The odds ratios from the individual trials were combined using appropriate methods of meta-analysis. For continuous outcomes the mean and standard deviation of these measures were assessed (Weighted mean difference [WMD]). Trials were included if they met quality assessment criteria A or B according to the handbook. A cut-off of two points was used in the Jadad scale to check the assessment made by the Handbook criteria. Heterogeneity in the results of the trials was assessed both by inspection of graphical presentations and by calculating a test of heterogeneity using a X2 statistic. RESULTS: Preliminary analysis of 20 trials included in this meta-analysis showed a statistically significant effect in favor of antidepressants over placebo on the following outcomes: a) remission of bulimic symptoms (OR:0.54[0.36,0.82]); b) clinical improvement (OR:0.35[0.26,0.47]); c) difference in bulimic symptoms (WMD:-2.678[-3.865, -1.491]); and a significant difference on drop-outs due to adverse effects in favor of placebo (OR:2.11[1.35,3.32]). CONCLUSION: Antidepressants appear to be effective compared to placebo for the treatment of BN.
Publication Types:
Keywords:
- 6-bromo-2-naphthyl sulfate
- Adolescent
- Adult
- Antidepressive Agents
- Bulimia
- Clinical Trials as Topic
- Combined Modality Therapy
- Female
- Humans
- Meta-Analysis
- Naphthalenes
- Odds Ratio
- Pharmaceutical Preparations
- Placebos
- Randomized Controlled Trials as Topic
- Research Design
- therapy
- hsrmtgs
Other ID:
UI: 102237260
From Meeting Abstracts